COMMUNIQUÉS West-GlobeNewswire

Editas Medicine Announces Transition of Chief Financial Officer
21/12/2018
CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that its Chief Financial Officer, Andrew Hack, M.D., Ph.D., will be stepping [...]
Novartis successfully completes acquisition of Endocyte
21/12/2018
Adds 177 Lu-PSMA-617, a potential first-in-class radioligand therapy in Phase III development for metastatic castration-resistant prostate cancer (mCRPC) Strengthens leadership in nuclear medicine and radioligand [...]
Align Technology Receives Multiple Product Awards for iTero Element 2 and iTero Element Flex Scanners
21/12/2018
SAN JOSE, Calif., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today that the iTero Element 2 and iTero Element Flex scanners have been honored with multiple product awards from two [...]
Microbix Reports Results for Fiscal 2018
21/12/2018
Full-Year Sales Growth of 23%, Progress Toward Sustained Profitability TORONTO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, [...]
TRACON Pharmaceuticals Announces Top-line Data from Phase 2 TRAXAR Clinical Trial in Renal Cell Carcinoma
21/12/2018
SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Novo Nordisk A/S: Share repurchase programme
21/12/2018
Bagsværd, Denmark, 21 December 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE
21/12/2018
RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE Milan, 21 December 2018 – Recordati announces the signing of an agreement for the acquisition of 100% of the share capital of Tonipharm S.A.S., a French company based in [...]
Ziopharm Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
BOSTON, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 37 th Annual J.P. Morgan Healthcare [...]
CTD Holdings Closes $2.0 Million Private Placement
21/12/2018
ALACHUA, Fla., Dec. 21, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]
Entry into a Material Definitive Agreement
21/12/2018
MIAMI, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ) (the “Company”) a personalized healthcare services and technology company, announced today that, through its wholly-owned subsidiary, [...]
Project HOPE Deploys Medical Team to Colombian Border Towns to Ease Suffering of Venezuelans
21/12/2018
Millwood, VA, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Project HOPE says it is scaling up its medical response in the border regions in Colombia as thousands of displaced Venezuelans continue to pour across the border each day [...]
Abattis Provides Marketing and Operational Updates
21/12/2018
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce the launch of its new website and provide an [...]
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat
21/12/2018
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat Licensing rights are worldwide excluding US, Canada, Japan and South America Lugano, Switzerland and Florence, Italy, December 21, 2018: [...]
Nemaura Announces Completion of Key Stages of Technical File Review for SugarBEAT® CE Mark Approval
21/12/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]
United States Patent and Trademark Office Issues Composition of Matter Patent with BeyondSpring’s Lead Asset Plinabulin with Protection to 2036
21/12/2018
NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the United States Patent [...]
Rockwell Medical, Inc. to Present at Biotech Showcase™ 2019
21/12/2018
WIXOM, Mich., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at Biotech Showcase™ [...]
Surface Oncology Added to the NASDAQ Biotechnology Index
21/12/2018
CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced [...]
Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne
21/12/2018
REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing [...]
Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan
21/12/2018
-Financing Strengthens Cash Position Ahead of Two Potential Product Launches in 2019- DUBLIN, Ireland, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company [...]

Pages